Global and United States Prucalopride Market Report & Forecast 2023-2028

Report ID: 1828582 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Prucalopride Product Introduction
    1.2 Global Prucalopride Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Prucalopride Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Prucalopride Sales in Volume for the Year 2017-2028
    1.3 United States Prucalopride Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Prucalopride Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Prucalopride Sales in Volume for the Year 2017-2028
    1.4 Prucalopride Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Prucalopride in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Prucalopride Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Prucalopride Market Dynamics
        1.5.1 Prucalopride Industry Trends
        1.5.2 Prucalopride Market Drivers
        1.5.3 Prucalopride Market Challenges
        1.5.4 Prucalopride Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Prucalopride Market Segment by Type
        2.1.1 1 mg
        2.1.2 2 mg
    2.2 Global Prucalopride Market Size by Type
        2.2.1 Global Prucalopride Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Prucalopride Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Prucalopride Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Prucalopride Market Size by Type
        2.3.1 United States Prucalopride Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Prucalopride Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Prucalopride Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Prucalopride Market Segment by Application
        3.1.1 Offline Channel
        3.1.2 Online Channel
    3.2 Global Prucalopride Market Size by Application
        3.2.1 Global Prucalopride Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Prucalopride Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Prucalopride Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Prucalopride Market Size by Application
        3.3.1 United States Prucalopride Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Prucalopride Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Prucalopride Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prucalopride Competitor Landscape by Company
    4.1 Global Prucalopride Market Size by Company
        4.1.1 Top Global Prucalopride Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Prucalopride Revenue by Manufacturer (2017-2022)
        4.1.3 Global Prucalopride Sales by Manufacturer (2017-2022)
        4.1.4 Global Prucalopride Price by Manufacturer (2017-2022)
    4.2 Global Prucalopride Concentration Ratio (CR)
        4.2.1 Prucalopride Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prucalopride in 2021
        4.2.3 Global Prucalopride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Prucalopride Manufacturing Base Distribution, Product Type
        4.3.1 Global Prucalopride Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Prucalopride Product Type
        4.3.3 Date of International Manufacturers Enter into Prucalopride Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Prucalopride Market Size by Company
        4.5.1 Top Prucalopride Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Prucalopride Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Prucalopride Sales by Players (2020, 2021 & 2022)
5 Global Prucalopride Market Size by Region
    5.1 Global Prucalopride Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Prucalopride Market Size in Volume by Region (2017-2028)
        5.2.1 Global Prucalopride Sales in Volume by Region: 2017-2022
        5.2.2 Global Prucalopride Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Prucalopride Market Size in Value by Region (2017-2028)
        5.3.1 Global Prucalopride Sales in Value by Region: 2017-2022
        5.3.2 Global Prucalopride Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Prucalopride Market Size YoY Growth 2017-2028
        6.1.2 North America Prucalopride Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Prucalopride Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Prucalopride Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Prucalopride Market Size YoY Growth 2017-2028
        6.3.2 Europe Prucalopride Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Prucalopride Market Size YoY Growth 2017-2028
        6.4.2 Latin America Prucalopride Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Prucalopride Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Prucalopride Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Corporation Information
        7.1.2 Takeda Description and Business Overview
        7.1.3 Takeda Prucalopride Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Takeda Prucalopride Products Offered
        7.1.5 Takeda Recent Development
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Corporation Information
        7.2.2 Johnson & Johnson Description and Business Overview
        7.2.3 Johnson & Johnson Prucalopride Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Johnson & Johnson Prucalopride Products Offered
        7.2.5 Johnson & Johnson Recent Development
    7.3 Apotex Corporation
        7.3.1 Apotex Corporation Corporation Information
        7.3.2 Apotex Corporation Description and Business Overview
        7.3.3 Apotex Corporation Prucalopride Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Apotex Corporation Prucalopride Products Offered
        7.3.5 Apotex Corporation Recent Development
    7.4 Jamp Pharma Corporation
        7.4.1 Jamp Pharma Corporation Corporation Information
        7.4.2 Jamp Pharma Corporation Description and Business Overview
        7.4.3 Jamp Pharma Corporation Prucalopride Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Jamp Pharma Corporation Prucalopride Products Offered
        7.4.5 Jamp Pharma Corporation Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Prucalopride Industry Chain Analysis
    8.2 Prucalopride Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Prucalopride Distributors
    8.3 Prucalopride Production Mode & Process
    8.4 Prucalopride Sales and Marketing
        8.4.1 Prucalopride Sales Channels
        8.4.2 Prucalopride Distributors
    8.5 Prucalopride Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Prucalopride CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Prucalopride Market Trends
    Table 3. Prucalopride Market Drivers
    Table 4. Prucalopride Market Challenges
    Table 5. Prucalopride Market Restraints
    Table 6. Global Prucalopride Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Prucalopride Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Prucalopride Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Prucalopride Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Prucalopride Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Prucalopride Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Prucalopride Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Prucalopride Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Prucalopride Sales Share by Manufacturer, 2017-2022
    Table 15. Global Prucalopride Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Prucalopride Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Prucalopride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prucalopride as of 2021)
    Table 18. Top Players of Prucalopride in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Prucalopride Product Type
    Table 20. Date of International Manufacturers Enter into Prucalopride Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Prucalopride Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Prucalopride Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Prucalopride Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Prucalopride Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Prucalopride Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Prucalopride Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Prucalopride Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Prucalopride Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Prucalopride Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Prucalopride Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Prucalopride Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Prucalopride Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Prucalopride Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Prucalopride Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Prucalopride Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Prucalopride Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Prucalopride Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Prucalopride Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Prucalopride Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Prucalopride Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Takeda Corporation Information
    Table 43. Takeda Description and Business Overview
    Table 44. Takeda Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Takeda Prucalopride Product
    Table 46. Takeda Recent Development
    Table 47. Johnson & Johnson Corporation Information
    Table 48. Johnson & Johnson Description and Business Overview
    Table 49. Johnson & Johnson Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Johnson & Johnson Product
    Table 51. Johnson & Johnson Recent Development
    Table 52. Apotex Corporation Corporation Information
    Table 53. Apotex Corporation Description and Business Overview
    Table 54. Apotex Corporation Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Apotex Corporation Product
    Table 56. Apotex Corporation Recent Development
    Table 57. Jamp Pharma Corporation Corporation Information
    Table 58. Jamp Pharma Corporation Description and Business Overview
    Table 59. Jamp Pharma Corporation Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Jamp Pharma Corporation Product
    Table 61. Jamp Pharma Corporation Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Prucalopride Customers List
    Table 65. Prucalopride Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prucalopride Product Picture
    Figure 2. Global Prucalopride Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Prucalopride Market Size 2017-2028 (US$ Million)
    Figure 4. Global Prucalopride Sales 2017-2028 (K Units)
    Figure 5. United States Prucalopride Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Prucalopride Market Size 2017-2028 (US$ Million)
    Figure 7. United States Prucalopride Sales 2017-2028 (K Units)
    Figure 8. United States Prucalopride Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Prucalopride Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Prucalopride Report Years Considered
    Figure 11. Product Picture of 1 mg
    Figure 12. Product Picture of 2 mg
    Figure 13. Global Prucalopride Market Share by Type in 2022 & 2028
    Figure 14. Global Prucalopride Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Prucalopride Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Prucalopride Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Prucalopride Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Prucalopride Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Prucalopride Market Share by Type in 2022 & 2028
    Figure 20. United States Prucalopride Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Prucalopride Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Prucalopride Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Prucalopride Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Prucalopride Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Offline Channel
    Figure 26. Product Picture of Online Channel
    Figure 27. Global Prucalopride Market Share by Application in 2022 & 2028
    Figure 28. Global Prucalopride Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Prucalopride Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Prucalopride Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Prucalopride Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Prucalopride Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Prucalopride Market Share by Application in 2022 & 2028
    Figure 34. United States Prucalopride Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Prucalopride Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Prucalopride Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Prucalopride Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Prucalopride Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Prucalopride Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Prucalopride Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Prucalopride Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Prucalopride Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Prucalopride Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Prucalopride Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Prucalopride Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Prucalopride Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Prucalopride Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Prucalopride Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Prucalopride Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Prucalopride Value Chain
    Figure 73. Prucalopride Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
Johnson & Johnson
Apotex Corporation
Jamp Pharma Corporation
Frequently Asked Questions
Prucalopride report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prucalopride report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prucalopride report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Alverine Citrate

Alverine Citrate market is segmented by region (country), players, by Type and by Application. Pl ... Read More

Trimebutine

Trimebutine market is segmented by region (country), players, by Type and by Application. Players ... Read More